Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutat...

Full description

Saved in:
Bibliographic Details
Published inAntiviral research Vol. 54; no. 2; pp. 99 - 111
Main Authors Herlocher, M.L, Carr, J, Ives, J, Elias, S, Truscon, R, Roberts, N, Monto, A.S
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.05.2002
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets ( n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naı̈ve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.
AbstractList A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets ( n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naı̈ve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.
A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.
A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.
A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naive contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.
Author Herlocher, M.L
Elias, S
Roberts, N
Monto, A.S
Carr, J
Ives, J
Truscon, R
Author_xml – sequence: 1
  givenname: M.L
  surname: Herlocher
  fullname: Herlocher, M.L
  email: louise@umich.edu
  organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA
– sequence: 2
  givenname: J
  surname: Carr
  fullname: Carr, J
  organization: Viral Diseases, Roche Discovery Welwyn, 40 Broadwater Road, Welwn Garden City, Herts. AL6 3AY, UK
– sequence: 3
  givenname: J
  surname: Ives
  fullname: Ives, J
  organization: Viral Diseases, Roche Discovery Welwyn, 40 Broadwater Road, Welwn Garden City, Herts. AL6 3AY, UK
– sequence: 4
  givenname: S
  surname: Elias
  fullname: Elias, S
  organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA
– sequence: 5
  givenname: R
  surname: Truscon
  fullname: Truscon, R
  organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA
– sequence: 6
  givenname: N
  surname: Roberts
  fullname: Roberts, N
  organization: Viral Diseases, Roche Discovery Welwyn, 40 Broadwater Road, Welwn Garden City, Herts. AL6 3AY, UK
– sequence: 7
  givenname: A.S
  surname: Monto
  fullname: Monto, A.S
  organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13618588$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12062395$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1rFTEYhYNU7G31JyjZWHQx-uZzMriQUvwoLQjafcjNvKmRmUxNMoX6653be7XQzYWQbJ5zIOc5IgdpSkjISwbvGDD9_sdy6UYoyd8AewvAmWzUE7JipuVNB50-IKv_yCE5KuUXAOi2M8_IIeOguejUiqzPUxhmTH8cvY15LtS7nO9iuqYu0e-84xd0nKurcUo0Jlp_Ik04ZzfGFHtXkF5jQhoLTVOlNbtUxlgr9hs4YM5Yy3PyNLih4Ivde0yuPn-6OvvaXH77cn52etl4Idra-E4ZDUqGsNZCCmGEgy6IgIJrKdFLBmaNrvctCNEbkKH3wfHOByNQKXFMTra1N3n6PWOpdozF4zC4hNNcbMsMX47eCzIjoONKLuCrHTivR-ztTY6jy3f233oL8HoHuOLdEJbv-1geOKGZUcYsnNpyPk-lZAwPCNiNTXtv025UWWD23qbd9H94lPNx62JZOg570x-3aVxGv42YbfERk8c-ZvTV9lPc0_AXz223uQ
CODEN ARSRDR
CitedBy_id crossref_primary_10_1128_JVI_01226_08
crossref_primary_10_1093_infdis_jiu353
crossref_primary_10_1016_j_antiviral_2007_12_010
crossref_primary_10_1016_S0140_6736_04_16934_1
crossref_primary_10_1128_AAC_47_7_2264_2272_2003
crossref_primary_10_1128_AAC_49_11_4515_4520_2005
crossref_primary_10_1128_JVI_01081_13
crossref_primary_10_1586_14787210_4_5_795
crossref_primary_10_1016_j_virol_2011_02_015
crossref_primary_10_1017_S1462399410001705
crossref_primary_10_1128_JVI_00898_16
crossref_primary_10_1002_ange_200602623
crossref_primary_10_1002_biot_200600159
crossref_primary_10_1086_596312
crossref_primary_10_1038_nrd2175
crossref_primary_10_1016_j_antiviral_2012_07_002
crossref_primary_10_1371_journal_ppat_1002276
crossref_primary_10_1073_pnas_0605134103
crossref_primary_10_1517_13543776_14_8_1153
crossref_primary_10_1016_S0140_6736_13_61209_X
crossref_primary_10_1016_j_antiviral_2021_105060
crossref_primary_10_1371_journal_pone_0071230
crossref_primary_10_1093_cid_ciab625
crossref_primary_10_1016_j_rinp_2021_104390
crossref_primary_10_1371_journal_pone_0200849
crossref_primary_10_1016_j_patbio_2010_01_011
crossref_primary_10_1016_j_coviro_2014_04_009
crossref_primary_10_1155_2014_430629
crossref_primary_10_1063_1674_0068_cjcp2110193
crossref_primary_10_1128_JVI_01067_07
crossref_primary_10_1140_epjp_s13360_022_03302_5
crossref_primary_10_1128_JVI_00689_10
crossref_primary_10_1016_S0025_7753_05_72189_8
crossref_primary_10_3201_eid1606_091623
crossref_primary_10_1128_JVI_00373_10
crossref_primary_10_1128_AAC_02628_13
crossref_primary_10_1016_S1473_3099_11_70318_8
crossref_primary_10_1017_S1466252310000137
crossref_primary_10_1111_j_1750_2659_2007_00008_x
crossref_primary_10_1177_095632020201300401
crossref_primary_10_1128_AAC_01773_10
crossref_primary_10_7554_eLife_07969
crossref_primary_10_1128_CDLI_11_1_21_28_2004
crossref_primary_10_1126_science_1122947
crossref_primary_10_1093_jac_dkw275
crossref_primary_10_1016_j_antiviral_2011_11_006
crossref_primary_10_3201_eid1909_130724
crossref_primary_10_1097_01_inf_0000144680_39895_ce
crossref_primary_10_1016_j_antiviral_2009_09_010
crossref_primary_10_1097_QCO_0b013e3283199797
crossref_primary_10_2165_00151829_200504020_00004
crossref_primary_10_1128_AAC_01699_10
crossref_primary_10_1128_JVI_06901_11
crossref_primary_10_1007_s12250_013_3307_8
crossref_primary_10_1097_MJT_0b013e3180a7206e
crossref_primary_10_1186_1471_2334_9_8
crossref_primary_10_1111_irv_12356
crossref_primary_10_2165_11531450_000000000_00000
crossref_primary_10_1093_infdis_jiq067
crossref_primary_10_1242_dmm_007823
crossref_primary_10_1128_AAC_03667_14
crossref_primary_10_1016_j_antiviral_2008_01_003
crossref_primary_10_1016_j_ics_2004_02_060
crossref_primary_10_1016_j_coviro_2011_08_006
crossref_primary_10_1177_135965350701200S04_1
crossref_primary_10_1186_s13567_014_0142_3
crossref_primary_10_1371_journal_pcbi_1002026
crossref_primary_10_1371_journal_pcbi_0030240
crossref_primary_10_3201_eid1502_081031
crossref_primary_10_1177_135965350601100804
crossref_primary_10_1371_journal_ppat_1001022
crossref_primary_10_1016_j_antiviral_2016_11_007
crossref_primary_10_1128_AAC_49_10_4075_4084_2005
crossref_primary_10_1016_j_jcv_2007_10_020
crossref_primary_10_1016_j_virusres_2004_02_035
crossref_primary_10_1002_jmv_20951
crossref_primary_10_1080_02648725_2023_2191081
crossref_primary_10_1080_17460441_2018_1540586
crossref_primary_10_2217_thy_11_79
crossref_primary_10_1016_j_jviromet_2013_02_016
crossref_primary_10_1128_AAC_01339_05
crossref_primary_10_1128_JCM_43_8_4139_4146_2005
crossref_primary_10_1111_j_1440_1843_2008_01404_x
crossref_primary_10_1002_anie_200602623
crossref_primary_10_1016_j_jim_2014_03_023
crossref_primary_10_1093_infdis_jiu447
crossref_primary_10_1016_j_vetmic_2009_09_068
crossref_primary_10_1016_j_coi_2011_07_016
crossref_primary_10_1016_S0140_6736_04_16947_X
crossref_primary_10_1111_j_1469_0691_2007_01910_x
crossref_primary_10_1128_mBio_00396_13
crossref_primary_10_1016_j_antiviral_2018_04_009
crossref_primary_10_3390_v2081510
crossref_primary_10_1098_rstb_2001_1002
crossref_primary_10_3201_eid1201_051068
crossref_primary_10_1098_rsif_2011_0427
crossref_primary_10_1098_rsif_2007_1126
crossref_primary_10_1371_journal_ppat_1009527
crossref_primary_10_1093_jac_dkq012
crossref_primary_10_1016_j_coviro_2011_07_003
crossref_primary_10_1128_AAC_01608_09
crossref_primary_10_1111_irv_12047
crossref_primary_10_1128_AAC_02126_12
crossref_primary_10_1111_irv_12044
crossref_primary_10_1128_AAC_01848_13
crossref_primary_10_1111_irv_12043
Cites_doi 10.1093/clinids/10.1.56
10.1128/AAC.39.11.2583
10.1128/JVI.72.3.2456-2462.1998
10.1086/314713
10.1093/infdis/141.3.351
10.1128/AAC.42.3.640
10.1093/jac/1.suppl_4.35
10.1099/0022-1317-75-10-2835
10.1128/JVI.71.5.3385-3390.1997
10.1016/S0166-3542(00)00103-0
10.1093/infdis/146.6.780
10.1016/0166-0934(89)90004-9
10.1056/NEJM198912213212502
10.1128/AAC.42.12.3234
10.1086/322801
10.1016/S0531-5131(01)00365-X
10.1016/S0166-3542(00)90410-8
10.1006/bbrc.1998.8282
10.1006/viro.1998.9194
10.1093/infdis/164.5.969
10.2165/00003495-199855050-00015
10.1128/AAC.37.7.1473
ContentType Journal Article
Copyright 2002 Elsevier Science B.V.
2002 INIST-CNRS
Copyright_xml – notice: 2002 Elsevier Science B.V.
– notice: 2002 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
7X8
DOI 10.1016/S0166-3542(01)00214-5
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1872-9096
EndPage 111
ExternalDocumentID 12062395
13618588
10_1016_S0166_3542_01_00214_5
S0166354201002145
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
23M
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AAAJQ
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATCM
AAXUO
ABBQC
ABFNM
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CJTIS
CNWQP
CS3
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMG
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SIN
SPCBC
SSH
SSI
SSP
SSZ
T5K
TEORI
WUQ
ZGI
ZXP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACIEU
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
EFKBS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
7X8
ID FETCH-LOGICAL-c337t-c9586054ffb6343383a09f3fe32644ec4108beadc7033d804fdcfa29cf83e553
IEDL.DBID .~1
ISSN 0166-3542
IngestDate Fri Jul 11 04:04:02 EDT 2025
Fri Jul 11 10:33:09 EDT 2025
Wed Feb 19 01:32:37 EST 2025
Mon Jul 21 09:16:45 EDT 2025
Tue Jul 01 03:27:37 EDT 2025
Thu Apr 24 22:56:24 EDT 2025
Fri Feb 23 02:25:05 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Resistance
Influenza
Ferret
Transmission
Neuraminidase
Fissipedia
Carnivora
Enzyme
Orthomyxoviridae
Influenzavirus
Host virus relation
Infection
Virus
Vertebrata
Mammalia
Glycosidases
Animal
Exo-α-sialidase
Viral disease
Hydrolases
Mutation
O-Glycosidases
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c337t-c9586054ffb6343383a09f3fe32644ec4108beadc7033d804fdcfa29cf83e553
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 12062395
PQID 18309254
PQPubID 23462
PageCount 13
ParticipantIDs proquest_miscellaneous_71821826
proquest_miscellaneous_18309254
pubmed_primary_12062395
pascalfrancis_primary_13618588
crossref_primary_10_1016_S0166_3542_01_00214_5
crossref_citationtrail_10_1016_S0166_3542_01_00214_5
elsevier_sciencedirect_doi_10_1016_S0166_3542_01_00214_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2002-May
PublicationDateYYYYMMDD 2002-05-01
PublicationDate_xml – month: 05
  year: 2002
  text: 2002-May
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle Antiviral research
PublicationTitleAlternate Antiviral Res
PublicationYear 2002
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Blick, Sahasrabudhe, McDonald, Owens, Morley, Fenton, McKimm-Breschkin (BIB4) 1998; 246
McKimm-Breschkin, Sahasrabudhe, Blick, McDonald, Colman, Hart, Bethell, Varghese (BIB20) 1998; 72
Li, Liu, Klimov, Subbarao, Perdue, Me, Ji, Woods, Hietala, Bryant (BIB17) 1999; 179
Bantia, Ananth, Horn, Parker, Gulati, Chand, Babu, Air (BIB3) 2000; 46
Herlocher, Elias, Truscon, Harrison, Mindell, Simon, Monto (BIB13) 2001; 184
Truscon, R., Herlocher, M.L., Klimov, A., Monto, A.S., 2001. Generating amantadine- resistant influenza using a ferret model. In: American Society for Virology 20th Annual Meeting Scientific Programs and Abstracts, University of Wisconsin, Madison, WI, 21–25 July 2001, pp. 107.
Reuman, Keely, Schiff, James (BIB23) 1989; 24
Carr, Ives, Roberts, Kelly, Lambkin, Oxford, Tai, Mendel, Hayden (BIB6) 2000; 46
Ives, Carr, Roberts, Tai, Mendel, Kelly, Lambkin, Oxford (BIB14) 2000; 18
Kati (BIB16) 1998; 244
Hayden, Belshe, Clover, Hay, Oakes, Soo (BIB11) 1989; 321
Alluwaimi, Smith, Sweet (BIB1) 1994; 75
Ferguson, Mallet (BIB7) 2001; 50
Maassab, Kendal, Abrams, Monto (BIB18) 1982; 146
Ryan, Ticehurst, Dempsey (BIB24) 1995; 39
Squires, Belyavin (BIB26) 1975; 1
Mendel, Tai, Escarpe, Li, Sidwell, Hoffinan, Sweet, Jakeman, Merson, Lacy, Lew, Williams, Zhang, Chen, Bishofberger, Kim (BIB22) 1998; 42
Sweet, Hayden, Jakeman, Grambas, Hay (BIB27) 1991; 164
Andrewes, Glover (BIB2) 1941; 22
Herlocher, M.L., Fenton, R., Merry, A., Elias, S., Monto A.S., 2001a. Influenza resistance to zanamivir generated in ferrets. In: Osherhaus A.D.M.E., Hampson A., Cox N. (Eds.), Options for the Control of Influenza IV. Elsevier Science, pp. 863–878.
Matsuyama, Sweet, Collie, Smith (BIB19) 1980; 141
Finney (BIB8) 1952
Hayden, Hay (BIB10) 1992; 176
Waghorn, Goa (BIB31) 1998; 55
McKimm-Breschkin (BIB21) 2000; 47
Smith, Sweet (BIB25) 1988; 10
Toms, Bird, Kingsman, Sweet, Smith (BIB29) 1976; 57
Tai, Escarpe, Sidwell, Willams, Lew, Wu, Kim, Mendel (BIB28) 1998; 42
Gubareva, Robinson, Bethell, Webster (BIB9) 1997; 71
Carr, J., Roberts, N., Tai, C.Y., Wang, M., Mendel, D.B., Kelly, L., Lambkin, R., Oxford, J., 1999. An oseltamivir-treatment selected influenza A: Wuhan/359/95 virus with an e119v mutation in the neuraminidase gene has reduced infectivity in vivo (Abstract). In: Kaiser, L., Couch, R.B., Galasso, G.J., Glezen, W.P., Webster, R.G., Wright, P.F., Hayden, F.G, First International Symposium on Influenza and Other Respiratory Viruses: Summary and Overview: Kapalua, Maui, Hawaii, 4–6 December 1998.
Ives, Carr, Roberts, Tai, Mendel, Kelly, Lambkin, Oxford (BIB15) 2000; 18
Woods (BIB32) 1993; 37
Bantia (10.1016/S0166-3542(01)00214-5_BIB3) 2000; 46
Mendel (10.1016/S0166-3542(01)00214-5_BIB22) 1998; 42
Ferguson (10.1016/S0166-3542(01)00214-5_BIB7) 2001; 50
Blick (10.1016/S0166-3542(01)00214-5_BIB4) 1998; 246
Finney (10.1016/S0166-3542(01)00214-5_BIB8) 1952
Hayden (10.1016/S0166-3542(01)00214-5_BIB10) 1992; 176
Squires (10.1016/S0166-3542(01)00214-5_BIB26) 1975; 1
McKimm-Breschkin (10.1016/S0166-3542(01)00214-5_BIB20) 1998; 72
Kati (10.1016/S0166-3542(01)00214-5_BIB16) 1998; 244
Reuman (10.1016/S0166-3542(01)00214-5_BIB23) 1989; 24
Hayden (10.1016/S0166-3542(01)00214-5_BIB11) 1989; 321
Matsuyama (10.1016/S0166-3542(01)00214-5_BIB19) 1980; 141
Ives (10.1016/S0166-3542(01)00214-5_BIB15) 2000; 18
McKimm-Breschkin (10.1016/S0166-3542(01)00214-5_BIB21) 2000; 47
Tai (10.1016/S0166-3542(01)00214-5_BIB28) 1998; 42
Toms (10.1016/S0166-3542(01)00214-5_BIB29) 1976; 57
10.1016/S0166-3542(01)00214-5_BIB5
Gubareva (10.1016/S0166-3542(01)00214-5_BIB9) 1997; 71
10.1016/S0166-3542(01)00214-5_BIB12
Herlocher (10.1016/S0166-3542(01)00214-5_BIB13) 2001; 184
Li (10.1016/S0166-3542(01)00214-5_BIB17) 1999; 179
Carr (10.1016/S0166-3542(01)00214-5_BIB6) 2000; 46
10.1016/S0166-3542(01)00214-5_BIB30
Alluwaimi (10.1016/S0166-3542(01)00214-5_BIB1) 1994; 75
Ives (10.1016/S0166-3542(01)00214-5_BIB14) 2000; 18
Woods (10.1016/S0166-3542(01)00214-5_BIB32) 1993; 37
Sweet (10.1016/S0166-3542(01)00214-5_BIB27) 1991; 164
Ryan (10.1016/S0166-3542(01)00214-5_BIB24) 1995; 39
Maassab (10.1016/S0166-3542(01)00214-5_BIB18) 1982; 146
Waghorn (10.1016/S0166-3542(01)00214-5_BIB31) 1998; 55
Andrewes (10.1016/S0166-3542(01)00214-5_BIB2) 1941; 22
Smith (10.1016/S0166-3542(01)00214-5_BIB25) 1988; 10
References_xml – volume: 244
  start-page: 408
  year: 1998
  end-page: 413
  ident: BIB16
  article-title: GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 46
  start-page: A1
  year: 2000
  end-page: A90
  ident: BIB3
  article-title: Generation and Characterisation of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor RWJ-270201
  publication-title: Antiviral Res.
– volume: 24
  start-page: 27
  year: 1989
  end-page: 34
  ident: BIB23
  article-title: Assessment of signs of influenza illness in the ferret model
  publication-title: J. Virol. Methods
– volume: 176
  start-page: 119
  year: 1992
  end-page: 130
  ident: BIB10
  article-title: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 72
  start-page: 2456
  year: 1998
  end-page: 2462
  ident: BIB20
  article-title: Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors
  publication-title: J. Virol.
– volume: 184
  start-page: 542
  year: 2001
  end-page: 546
  ident: BIB13
  article-title: Ferrets as a transmission model for influenza: sequence changes in the HA1 of type A (H3N2) virus
  publication-title: J. Infect. Dis.
– volume: 47
  start-page: 1
  year: 2000
  end-page: 17
  ident: BIB21
  article-title: Resistance of influenza viruses to neuraminidase inhibitors—a review
  publication-title: Antiviral Res.
– volume: 246
  start-page: 95103
  year: 1998
  ident: BIB4
  article-title: The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en
  publication-title: Virology
– volume: 57
  start-page: 37
  year: 1976
  end-page: 48
  ident: BIB29
  article-title: The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man
  publication-title: Br. J. Exp. Pathol.
– volume: 18
  start-page: 251
  year: 2000
  ident: BIB14
  article-title: An oseltamivir treatment-selected influenza AIN2 virus with a R292K mutation in the neuraminidase gene has reduced infectivity in vivo (P-321)
  publication-title: J. Clin. Virol.
– volume: 164
  start-page: 969
  year: 1991
  end-page: 972
  ident: BIB27
  article-title: Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets
  publication-title: J. Infect. Dis.
– volume: 37
  start-page: 1473
  year: 1993
  end-page: 1479
  ident: BIB32
  article-title: 4-Guanidino-2,4-dideoxy-2,3-dehydro-
  publication-title: Antimicrob. Agents Chemother.
– volume: 46
  start-page: A59
  year: 2000
  ident: BIB6
  article-title: Virological assessment in vitro and in vivo of an influenza HIN1 virus with a H274Y mutation in the neuraminidase gene (79)
  publication-title: Antiviral Res.
– volume: 50
  start-page: A85
  year: 2001
  ident: BIB7
  article-title: An epidemiological model of influenza to investigate the potential transmission of drug resistant virus during community use of antiviral treatment for influenza (165)
  publication-title: Antiviral Res.
– volume: 10
  start-page: 56
  year: 1988
  end-page: 75
  ident: BIB25
  article-title: Lessons for human influenza from pathogenicity studies with ferrets
  publication-title: Rev. Infect. Dis.
– volume: 1
  start-page: 35
  year: 1975
  end-page: 42
  ident: BIB26
  article-title: Free contact infection in ferret groups
  publication-title: J. Antimicrob. Chemother.
– volume: 42
  start-page: 640
  year: 1998
  end-page: 646
  ident: BIB22
  article-title: Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection
  publication-title: Antimicrob. Agents Chemother.
– volume: 39
  start-page: 2583
  year: 1995
  end-page: 2584
  ident: BIB24
  article-title: GG167 (4-guanidino-2,4-dideoxy2,3-dehydro-
  publication-title: Antimicrob. Agents Chemother.
– volume: 22
  start-page: 981
  year: 1941
  end-page: 997
  ident: BIB2
  article-title: Spread of infection from the respiratory tract of the ferret. 1. Transmission of influenza a virus
  publication-title: Br. J. Exp. Pathol.
– volume: 141
  start-page: 351
  year: 1980
  end-page: 360
  ident: BIB19
  article-title: Aspects of virulence in ferrets exhibited by influenza virus recombinants of known genetic constitution
  publication-title: J. Infect. Dis.
– volume: 321
  start-page: 1696
  year: 1989
  end-page: 16702
  ident: BIB11
  article-title: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
  publication-title: New Engl. J. Med.
– start-page: 524
  year: 1952
  end-page: 530
  ident: BIB8
  publication-title: Statistical Method in Biological Assay
– volume: 71
  start-page: 3385
  year: 1997
  end-page: 3390
  ident: BIB9
  article-title: Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4guanidino-Neu5Ac2en
  publication-title: J. Virol.
– volume: 42
  start-page: 323
  year: 1998
  end-page: 441
  ident: BIB28
  article-title: Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071
  publication-title: Antimicrob. Agents Chemother.
– volume: 18
  start-page: 255
  year: 2000
  end-page: 256
  ident: BIB15
  article-title: An oseltamivir treatment-selected influenza A/Wuhan/359/95 virus with a E119V mutation in the neuraminidase gene has reduced infectivity in vivo (P-330)
  publication-title: J. Clin. Virol.
– reference: Truscon, R., Herlocher, M.L., Klimov, A., Monto, A.S., 2001. Generating amantadine- resistant influenza using a ferret model. In: American Society for Virology 20th Annual Meeting Scientific Programs and Abstracts, University of Wisconsin, Madison, WI, 21–25 July 2001, pp. 107.
– volume: 55
  start-page: 721
  year: 1998
  end-page: 725
  ident: BIB31
  article-title: Zanamivir [Review]
  publication-title: Drugs
– reference: Herlocher, M.L., Fenton, R., Merry, A., Elias, S., Monto A.S., 2001a. Influenza resistance to zanamivir generated in ferrets. In: Osherhaus A.D.M.E., Hampson A., Cox N. (Eds.), Options for the Control of Influenza IV. Elsevier Science, pp. 863–878.
– volume: 146
  start-page: 780
  year: 1982
  end-page: 790
  ident: BIB18
  article-title: Evaluation of a cold-recombinant influenza virus vaccine in ferrets
  publication-title: J. Infect. Dis.
– reference: Carr, J., Roberts, N., Tai, C.Y., Wang, M., Mendel, D.B., Kelly, L., Lambkin, R., Oxford, J., 1999. An oseltamivir-treatment selected influenza A: Wuhan/359/95 virus with an e119v mutation in the neuraminidase gene has reduced infectivity in vivo (Abstract). In: Kaiser, L., Couch, R.B., Galasso, G.J., Glezen, W.P., Webster, R.G., Wright, P.F., Hayden, F.G, First International Symposium on Influenza and Other Respiratory Viruses: Summary and Overview: Kapalua, Maui, Hawaii, 4–6 December 1998.
– volume: 75
  start-page: 2835
  year: 1994
  end-page: 2840
  ident: BIB1
  article-title: Role of surface glycoproteins in influenza virus pyrogenicity
  publication-title: J. Gen. Virol.
– volume: 179
  start-page: 1132
  year: 1999
  end-page: 1138
  ident: BIB17
  article-title: Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses
  publication-title: J. Infect. Dis.
– volume: 50
  start-page: A85
  year: 2001
  ident: 10.1016/S0166-3542(01)00214-5_BIB7
  article-title: An epidemiological model of influenza to investigate the potential transmission of drug resistant virus during community use of antiviral treatment for influenza (165)
  publication-title: Antiviral Res.
– volume: 10
  start-page: 56
  year: 1988
  ident: 10.1016/S0166-3542(01)00214-5_BIB25
  article-title: Lessons for human influenza from pathogenicity studies with ferrets
  publication-title: Rev. Infect. Dis.
  doi: 10.1093/clinids/10.1.56
– volume: 39
  start-page: 2583
  year: 1995
  ident: 10.1016/S0166-3542(01)00214-5_BIB24
  article-title: GG167 (4-guanidino-2,4-dideoxy2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.39.11.2583
– volume: 72
  start-page: 2456
  year: 1998
  ident: 10.1016/S0166-3542(01)00214-5_BIB20
  article-title: Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.3.2456-2462.1998
– volume: 18
  start-page: 251
  year: 2000
  ident: 10.1016/S0166-3542(01)00214-5_BIB14
  article-title: An oseltamivir treatment-selected influenza AIN2 virus with a R292K mutation in the neuraminidase gene has reduced infectivity in vivo (P-321)
  publication-title: J. Clin. Virol.
– volume: 179
  start-page: 1132
  year: 1999
  ident: 10.1016/S0166-3542(01)00214-5_BIB17
  article-title: Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses
  publication-title: J. Infect. Dis.
  doi: 10.1086/314713
– volume: 141
  start-page: 351
  year: 1980
  ident: 10.1016/S0166-3542(01)00214-5_BIB19
  article-title: Aspects of virulence in ferrets exhibited by influenza virus recombinants of known genetic constitution
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/141.3.351
– volume: 46
  start-page: A1
  year: 2000
  ident: 10.1016/S0166-3542(01)00214-5_BIB3
  article-title: Generation and Characterisation of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor RWJ-270201
  publication-title: Antiviral Res.
– volume: 42
  start-page: 640
  year: 1998
  ident: 10.1016/S0166-3542(01)00214-5_BIB22
  article-title: Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.42.3.640
– volume: 1
  start-page: 35
  issue: 4 Suppl.
  year: 1975
  ident: 10.1016/S0166-3542(01)00214-5_BIB26
  article-title: Free contact infection in ferret groups
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/1.suppl_4.35
– volume: 75
  start-page: 2835
  year: 1994
  ident: 10.1016/S0166-3542(01)00214-5_BIB1
  article-title: Role of surface glycoproteins in influenza virus pyrogenicity
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-75-10-2835
– volume: 71
  start-page: 3385
  year: 1997
  ident: 10.1016/S0166-3542(01)00214-5_BIB9
  article-title: Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4guanidino-Neu5Ac2en
  publication-title: J. Virol.
  doi: 10.1128/JVI.71.5.3385-3390.1997
– volume: 47
  start-page: 1
  year: 2000
  ident: 10.1016/S0166-3542(01)00214-5_BIB21
  article-title: Resistance of influenza viruses to neuraminidase inhibitors—a review
  publication-title: Antiviral Res.
  doi: 10.1016/S0166-3542(00)00103-0
– volume: 146
  start-page: 780
  year: 1982
  ident: 10.1016/S0166-3542(01)00214-5_BIB18
  article-title: Evaluation of a cold-recombinant influenza virus vaccine in ferrets
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/146.6.780
– volume: 24
  start-page: 27
  year: 1989
  ident: 10.1016/S0166-3542(01)00214-5_BIB23
  article-title: Assessment of signs of influenza illness in the ferret model
  publication-title: J. Virol. Methods
  doi: 10.1016/0166-0934(89)90004-9
– volume: 321
  start-page: 1696
  year: 1989
  ident: 10.1016/S0166-3542(01)00214-5_BIB11
  article-title: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJM198912213212502
– start-page: 524
  year: 1952
  ident: 10.1016/S0166-3542(01)00214-5_BIB8
– ident: 10.1016/S0166-3542(01)00214-5_BIB30
– volume: 176
  start-page: 119
  year: 1992
  ident: 10.1016/S0166-3542(01)00214-5_BIB10
  article-title: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 42
  start-page: 323
  year: 1998
  ident: 10.1016/S0166-3542(01)00214-5_BIB28
  article-title: Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.42.12.3234
– volume: 184
  start-page: 542
  issue: 5
  year: 2001
  ident: 10.1016/S0166-3542(01)00214-5_BIB13
  article-title: Ferrets as a transmission model for influenza: sequence changes in the HA1 of type A (H3N2) virus
  publication-title: J. Infect. Dis.
  doi: 10.1086/322801
– ident: 10.1016/S0166-3542(01)00214-5_BIB12
  doi: 10.1016/S0531-5131(01)00365-X
– volume: 18
  start-page: 255
  year: 2000
  ident: 10.1016/S0166-3542(01)00214-5_BIB15
  article-title: An oseltamivir treatment-selected influenza A/Wuhan/359/95 virus with a E119V mutation in the neuraminidase gene has reduced infectivity in vivo (P-330)
  publication-title: J. Clin. Virol.
– volume: 46
  start-page: A59
  year: 2000
  ident: 10.1016/S0166-3542(01)00214-5_BIB6
  article-title: Virological assessment in vitro and in vivo of an influenza HIN1 virus with a H274Y mutation in the neuraminidase gene (79)
  publication-title: Antiviral Res.
  doi: 10.1016/S0166-3542(00)90410-8
– volume: 22
  start-page: 981
  year: 1941
  ident: 10.1016/S0166-3542(01)00214-5_BIB2
  article-title: Spread of infection from the respiratory tract of the ferret. 1. Transmission of influenza a virus
  publication-title: Br. J. Exp. Pathol.
– volume: 244
  start-page: 408
  year: 1998
  ident: 10.1016/S0166-3542(01)00214-5_BIB16
  article-title: GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1998.8282
– volume: 57
  start-page: 37
  year: 1976
  ident: 10.1016/S0166-3542(01)00214-5_BIB29
  article-title: The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man
  publication-title: Br. J. Exp. Pathol.
– volume: 246
  start-page: 95103
  year: 1998
  ident: 10.1016/S0166-3542(01)00214-5_BIB4
  article-title: The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en
  publication-title: Virology
  doi: 10.1006/viro.1998.9194
– ident: 10.1016/S0166-3542(01)00214-5_BIB5
– volume: 164
  start-page: 969
  year: 1991
  ident: 10.1016/S0166-3542(01)00214-5_BIB27
  article-title: Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/164.5.969
– volume: 55
  start-page: 721
  year: 1998
  ident: 10.1016/S0166-3542(01)00214-5_BIB31
  article-title: Zanamivir [Review]
  publication-title: Drugs
  doi: 10.2165/00003495-199855050-00015
– volume: 37
  start-page: 1473
  year: 1993
  ident: 10.1016/S0166-3542(01)00214-5_BIB32
  article-title: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.37.7.1473
SSID ssj0006798
Score 2.0471866
Snippet A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 99
SubjectTerms Animals
Biological and medical sciences
Disease Models, Animal
Disease Transmission, Infectious
DNA, Viral
Ferret
Ferrets - virology
Fever
Fundamental and applied biological sciences. Psychology
Genetics
Influenza
Influenza A virus - enzymology
Influenza A virus - genetics
Influenza virus
Male
Microbiology
Mutation
Nasal Lavage Fluid - virology
Neuraminidase
Neuraminidase - genetics
Orthomyxoviridae Infections - transmission
Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains
Resistance
Sequence Analysis, DNA
Transmission
Viral Load
Virology
Title Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets
URI https://dx.doi.org/10.1016/S0166-3542(01)00214-5
https://www.ncbi.nlm.nih.gov/pubmed/12062395
https://www.proquest.com/docview/18309254
https://www.proquest.com/docview/71821826
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hEFUlhIA-2JZufeihPYTNxnbiHBECLUXl0FKJm-U4thSpZFebLBIc-O2dibNdOKyQerXsSeQZz3yjeQF8sTT0LVU8ynKFDopJaMxLQmk71pZJLk0Run1epZPf4vuNvNmA02UtDKVV9ro_6PROW_cro_42R7OqGv1CsILWUlA4lxp_UaG5EBlJ-fHjKs2Dogyhv3ca0e5VFU-g0C1-jcffOiKRXGefdmamwVvzYdzFejza2aXzPdjtASU7Cf-8DxuuPoDtMGLy_gBe_eiD52-guAgDSR4Mu6vmi4ZZM59TlRMzNfuZ5Mklu12EyDyraobIkFG3S0PdR0o0dgxlzbGqYfW0ZS3ZuNuqRcBKm72jjN_mLVyfn12fTqJ-xEJkOc_ayOZSoUMjvC9SLshdNXHuuXecgJKzYhyrAoXNomLgpYqFL603SW694k5K_g4262ntDoH5MjNF5pCe84I7JBwnRpbSZxlCoHE2ALG8V2379uM0BeOPfpJnlqaa2KHjse7YoeUAjv8dm4X-Gy8dUEum6WeCpNFGvHR0-IzJqw_yFGGNUgP4vOS6xldIoRVTu-mi0agY4xx97fU7EANQs_x0AO-DuKyoJzFi0Fx--P8__wivuyk1XSLmEWy284X7hGCpLYbdaxjC1snF5eTqL9QwC1I
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VVgUkhGhpYYG2PnCAQ7rZ2E6cI6pabenHARapN8txbClSm11tskhw4LczE2dZelhV6tWyJ5FnPPOsGc8D-GiJ9C1VPMpyhRcUkxDNS0JlO9aWSS5NEbp9XqfjH-LrjbzZgJPlWxgqq-x9f_DpnbfuR4b9bg5nVTX8jmAFo6WgdC41_pJPYEvg8SUag-M_qzoPSjOEBt9pRNNXz3iCiG7wUzz63EmJ5LoA9WJmGtw2H_gu1gPSLjCdvYKXPaJkX8JP78CGq3dhO3BM_tqFp1d99vw1FOeBkeS3YT-r-aJh1szn9MyJmZp9S_Lkgt0tQmqeVTVDaMio3aWh9iMlRjuGxuZY1bB62rKWgtxd1SJipcneUclvsweTs9PJyTjqORYiy3nWRjaXCm80wvsi5YLuqybOPfeOE1JyVoxiVaC1WfQMvFSx8KX1JsmtV9xJyfdhs57W7i0wX2amyBzKc15wh4LjxMhS-ixDDDTKBiCW-6pt33-caDBu9X-FZmmqSR06HulOHVoO4PjfsllowPHQArVUmr5nSRqDxENLD-8pefVBniKuUWoAR0utazyGlFsxtZsuGo2eMc7xsr1-BoIA6pafDuBNMJeV9CRGEJrLd4__8yN4Np5cXerL8-uL9_C8o6zpqjI_wGY7X7gDRE5tcdidjL_WvQzg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+virus+carrying+an+R292K+mutation+in+the+neuraminidase+gene+is+not+transmitted+in+ferrets&rft.jtitle=Antiviral+research&rft.au=Herlocher%2C+M.L&rft.au=Carr%2C+J&rft.au=Ives%2C+J&rft.au=Elias%2C+S&rft.date=2002-05-01&rft.issn=0166-3542&rft.volume=54&rft.issue=2&rft.spage=99&rft.epage=111&rft_id=info:doi/10.1016%2FS0166-3542%2801%2900214-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0166_3542_01_00214_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0166-3542&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0166-3542&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0166-3542&client=summon